Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-01-04 @ 8:38 AM
Study NCT ID:
NCT04193904
Status:
TERMINATED
Last Update Posted:
2023-06-02
First Post:
2019-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer
Sponsor:
4D pharma plc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-12
First Submit QC Date:
None
Study First Post Date:
2019-12-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-01
Last Update Post Date:
2023-06-02
Last Update Post Date Type:
ACTUAL